01/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/09/2024

Sep 1, 2024, 09:51 | Blog
Sara Gutiérrez-Enríquez: Our Work on hereditary breast/ovarian cancer and Radiogenomics
Sara Gutiérrez-Enríquez, Molecular geneticist at Vall d'Hebron Institute of Oncology, shared a post on X:…
Sep 1, 2024, 09:48 | Insight
Phase III Keynote-789 Trial of Platinum + Pemetrexed +/- Pembrolizumab in EGFR + NSCLC
Jarushka Naidoo shared a post on X: "Phase  III Keynote-789 Trial of Platinum + Pemetrexed +/-Pembro…
Sep 1, 2024, 09:23 | Blog
Estela Rodriguez: The Inaugural class of Sylvester Comprehensive Cancer Center Emerging Leaders Program
Estela Rodriguez shared  on X: “Introducing the Inaugural class of Sylvester Comprehensive Cancer Center Emerging…
Sep 1, 2024, 09:17 | Insight
Geriatric assessment in oncology by Allison Magnuson et al.
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a recent article…
Sep 1, 2024, 09:14 | Insight
Power Of Metals Gold, Silver, and Copper in Our Daily Lives and Cancer Treatment - The Babak Lab
Maria Babak shared a post by The Babak Lab on LinkedIn, adding: "The Babak Lab is going…
Sep 1, 2024, 09:07 | Insight
Springboard Enterprises's 2024 Healthcare and Technology Council
Springboard Enterprises shared on LinkedIn: "Join us in welcoming our 2024 Healthcare and Technology Council, a…
Sep 1, 2024, 09:02 | Insight
Narjust Florez is one of the co-chairs at this year’s WCLC - Florez Lab
The Florez Lab shared on X: "Thrilled to share that Dr. Narjust Florez is one…
Sep 1, 2024, 09:00 | Blog
Nishant Rajendra Tiwari: Ryan Nipp on Practical considerations in Academic Medicine at OU Health Stephenson Cancer Center
Nishant Rajendra Tiwari, Hematology-Oncology Felllow at OU Health Stephenson Cancer Center, shared on X: "An…
Sep 1, 2024, 08:30 | Insight
Sacituzumab Govitecan in cisplatin-ineligible metastatic urothelial cancer after CPI
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic…
Sep 1, 2024, 08:24 | Insight
Rahul Banerjee: Chronicle disparities in Relapsed or Refractory myeloma and why they matter
Rahul Banerjee shared on X: "Now in Blood Cancer Journal - our work to chronicle…
All: 80 Posts: 61 - 70
Special Coverage